|
|
| | Tivozanib Basic information |
| Product Name: | Tivozanib | | Synonyms: | 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea;N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-urea monohydrochloride monohydrate;Tivozanib hydrochloride;Tivozanib hydrochloride hydrate;Tivozanib Hydrochloride Monohydrate | | CAS: | 682745-41-1 | | MF: | C22H22Cl2N4O6 | | MW: | 509.34 | | EINECS: | | | Product Categories: | | | Mol File: | 682745-41-1.mol |  |
| | Tivozanib Chemical Properties |
| storage temp. | 4°C, away from moisture and light | | solubility | DMSO : 250 mg/mL (490.83 mM; Need ultrasonic) | | form | Solid | | color | White to off-white |
| | Tivozanib Usage And Synthesis |
| Uses | Tivozanib also known as AV-951 is an orally bioavailable potent VEGFR-1, 2 and 3, c-Kit and PDGFR inhibitor with IC50 of 0.21, 0.16, 0.24, 1.63 and 1.72 nM, respectively. |
| | Tivozanib Preparation Products And Raw materials |
|